A case of recurrent gastric cancer successfully treated with TS-1

T. Onoda, S. Okamura, N. Takakura, S. Shiozaki, S. Ohno, K. Higaki, M. Ninomiya, T. Ikeda, N. Kobayashi

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)


A patient with recurrent gastric cancer which infiltrated the pelvic muscle after the treatment of paraaortic lymph node and ovarian metastases was successfully managed by a novel oral anticancer drug, TS-1. TS-1 was administered at a dose of 80 mg/day. One course consisted of two repetitions of consecutive administration of TS-1 for 14 days and withdrawal of TS-1 for 14 days. Adverse reactions were mild and the patient did not request hospitalization after two courses had been completed. Subjective symptoms such as difficulty in walking improved after one week and a partial response was obtained after 2 weeks of treatment. At the end of 4 courses we could remove an indwelling pyelocatheter for the ureter stricture. As of 14 months after the beginning of administration of TS-1, the patient is being treated as an outpatient and has attained a better QOL than before.

Original languageEnglish
Pages (from-to)539-542
Number of pages4
JournalGan to kagaku ryoho. Cancer & chemotherapy
Issue number4
Publication statusPublished - Apr 2001
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research


Dive into the research topics of 'A case of recurrent gastric cancer successfully treated with TS-1'. Together they form a unique fingerprint.

Cite this